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Abstract Objective To understand the genetic load in the Chinese population for improvement in diagnosis,
prevention and rehabilitation of deafness. Methods DNA samples, immortalized cell lines as well as detailed clinical
and audiometric data were collected through a national genetic resources collecting network. Two conventional
genetic approaches were used in the studies. Linkage analysis in X chromosome and autosomes with microsatellite
markers were performed in large families for gene mapping and positional cloning of novel genes. Candidate gene
approach was used for screening the mtDNA 12SrRNA, GJB2 and SLC26A4 mutations in population-based samples.
Results A total of 2,572 Chinese hearing loss families or sporadic cases were characterized in the reported studies,
including seven X-linked, one Y-linked, 28 large and multiplex autosomal dominant hearing loss families, 607
simplex autosomal recessive hereditary hearing loss families, 100 mitochondrial inheritance families, 147 GJB2
induced hearing loss cases, 230 cases with enlarged vestibular aqueduct（EVA）syndrome, 169 sporadic cases with
auditory neuropathy, and 1,283 sporadic sensorineural hearing loss cases. Through linkage analysis or sequence
analysis, two X-linked families were found transmitting two novel mutations in the POU3F4 gene, while another
X-linked family was mapped onto a novel locus, nominated as AUNX1（auditory neuropathy, X-linked locus 1）. The
only Y-linked family was mapped onto the DFNY1 locus（Y-linked locus 1, DFNY1）. Eight of the 28 autosomal
dominant families were linked to various autosomal loci. In population genetics studies, 2,567 familial cases and
sporadic patients were subjected to mutation screening for three common hearing loss genes: mtDNA 12S rRNA
1555G, GJB2 and SLC26A4. The auditory neuropathy cases in our samples were screened for OTOF gene mutations.
Conclusions These data show that the Chinese population has a genetic load on hereditary hearing loss. Establishing
personalized surveillance and prevention models for hearing loss based on genetic research will provide the
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opportunity to decrease the prevalence of deafness in the Chinese population.
Key words Hereditary hearing loss, linkage analysis, DFNY1, AUNX1, auditory neuropathy, enlarged vestibular
aqueduct, senserineural hearing loss, genetic epidemiology
Introduction
The second national census in 2006（http://www.cdpf.
org.cn）showed that there were a total of 82.96 million
disabled people in China, of which 27.8 million（34%）
had a hearing disability. This number continues to grow,
with 30,000 new deaf cases every year. Currently, the on⁃
ly effective intervention for congenital profound hearing
loss or deaf patients is cochlear implantation. Currently
in China, the minimal cost for cochlear implantation and
following rehabilitation is 300,000 yuan（roughly $44,
118）. A total treatment cost for the 27.8 million people
would be 8,000 billion yuan（$1,176 billions）. The annu⁃
al incremental medical cost for the 30,000 new deaf ba⁃
bies could impose an up to 9 billion yuan（$1.3 billion）
bill on China economy. Rapidly accumulating evidence
in the last decades demonstrates that genetic factors con⁃
tribute substantially and broadly to communication disor⁃
ders in various races and geographic regions in the
world. Therefore, there is a great demand for genetic
studies to elucidate the underlying mechanisms for he⁃
reditary hearing loss, which can provide increased in⁃
sights onto developing effective prevention and interven⁃
tional measures.
Genetic factors contribute to 50% of deafness cases
including syndromic（30%）and non-syndromic（70%）
hearing impairment［1, 2］. Recent times have witnessed rapid
progress in the field of genetic studies of hereditary hear⁃
ing impairment, especially of non-syndromic hearing im⁃
pairment. Transmission of non-syndromic hearing im⁃
pairment can be autosomal recessive（77%）, autosomal
dominant（22%）, X-linked（1%）, matrili- neal（mito⁃
chondrial inheritance, about 1%）, or Y-lin- ked［3-5］.
More than 146 chromosomal loci and at least 78 genes
（http://webhost.ua.ac.be/hhh） have been identified so
far. Recent advancements in hearing loss genetic studies
have provided a better understanding of the genetic mu⁃
tations that cause prelingual deafness ［6］. There have
been reports revealing that prelingual severe or profound
hearing loss is mainly due to recessive inheritance, and
the mutations in GJB2（DNFB1, OMIM: 121011) and
SLC26A4（DFNB4, OMIM: 600791）genes are thought
to be the major causes of autosomal recessive nonsyn⁃
dromic deafness［7］. GJB2 gene mutation is currently rec⁃
ognized to be respon-sible for both nonsyndromic auto⁃
somal recessive and sporadic prelingual deafness［8, 9］.
Mutations in the SLC26A4 gene have been identified as
a major cause for nonsyndromic hearing loss associated
with enlarged vestibular aqueduct（EVA）and Pendred
syndr－ome［10, 11］. The 1555A>G mitochondrial mutation
in the highly conserved coding region of the mitochondri⁃
al 12S rRNA gene has been found to be the most preva⁃
lent mitochondrial mutation associated with both amino⁃
glycoside-induced and nonsyndromic sensorineural
hearing loss（OMIM: 561000）in many ethnic origins［12,
13］.
Our questions are: What is the genetically attributed
prevalence of hearing impairment in the Chinese popula⁃
tion? What are the unique mutation profiles in hearing
impairment in the Chinese population? And what can be
done to decrease the prevalence of hearing impairment
in the Chinese population?
Methods
1. Subject collection and audiological evaluation
Genetic resources are essential for finding novel loci/
genes and for characterizing genetic epidemiological pa⁃
rameters of hereditary hearing loss. With the help from
the Audiology Development Foundation of China（in
provincial, municipal and county jurisdictions）, we ini⁃
tialized a nation-wide campaign in 2000 for collecting
genetic resources related to hearing loss and for con⁃
structing a large-scale database to document Chinese
patients including case-enriched families or sporadic
subjects. Subjects in the studies were either identified
through the national network covering most regions of
China or from patients who directly visited our clinic.
Control subjects were either randomly sampled normal
hearing individuals or patients of different disease cate⁃
gorizations than the phenotype under this study. Addi⁃
tional efforts were devoted in collecting pedigree-based
samples once a proband was identified, including pedi⁃
gree extension by procuring the demographic and audio⁃
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metric data, and DNA samples for their relatives. The
protocols of collecting the genetic resources were ap⁃
proved by the Chinese PLA General Hospital Institution
Review Board of the Ethics Committee. All hearing loss
patients and their relatives involved in the studies gave
their informed consents. The data summarized here were
collected from 2000 to 2007. Since 2007, we have begun
newborn hearing concurrent gene screening and resourc⁃
es samples have accumulated quickly to more than 25,
000.
Clinical evaluation was conducted according to the
protocols approved by the PLA General Hospital IRB.
All participants were extensively interviewed by experi⁃
enced otoloaryngologists to identify personal or family
evidence of hearing impairment, tinnitus, vestibular
symptoms, use of aminoglycosides, and other clinical ab⁃
normalities. These subjects were then given physical ex⁃
aminations of the hair, skin, sclera, iris, mouth, maxilla,
mandible, eyes, interocular distance, spine, and extremi⁃
ties. Otolaryngological examinations focused on the auri⁃
cle, external auditory meatus, and tympanic membrane.
Audiometric evaluation included pure tone audiometry,
tympanometry and acoustic reflexes, and auditory brain⁃
stem responses. The audiometric data were categorized
based on the recommendations by the European HEAR
project, as described by Stephens［14］. Sensorineural hear⁃
ing impairment was defined as an air/bone gap ⦤15 dB
hearing loss averaged over 0.5, 1, and 2 kHz. The severi⁃
ty of hearing impairment was applied to the better hear⁃
ing ear, averaged over 0.5, 1, 2, and 4 kHz and catego⁃
rized as following: mild: 20－40 dB HL; moderate: 41－
70 dB HL; severe: 71-95 dB HL; and profound: >95 dB
HL. Frequency ranges were defined as following: low fre⁃
quencies: ⦤0.5 kHz; mid frequencies: between 0.5 and
2 kHz（including 2 kHｚ）; high frequencies: between 2
and 8 kHz (including 8 kHz）; and extended high fre⁃
quencies: > 8 kHz.
2. Molecular procedures for DNA isolation, genotyp⁃
ing and sequencing
Genomic DNA from peripheral blood leukocytes was
obtained by the phenol/chloroform method. All PCR am⁃
plified products for the target fragments（microsatellites
or gene fragments for genes GJB2, SLC26A4 and mtDNA
12S rRNA A1555G） were purified with the Millipore
plate, and genotyped or sequenced with an ABI 3730 Se⁃
quencer（Applied Biosystems）. Genotypes at > 400 mo⁃
lecular markers, covering human genome every 10 cM
each, were used for linkage analysis. Sequence data
were analyzed by aligning with the reference sequences
in NCBI（NC_000013 for GJB2, NT_007933 for SLC26A
and AC_000021 for mtDNA 12S rRNA A1555G）using
the DNAStar 5.0 and BioEdit software. Mutations or
polymorphisms were identified per reference sequences.
GJB2 mutation screening The GJB2 gene has two ex⁃
ons, and the coding region is in exon 2. With the use of
the Primer 5.0 software package, the primer pair—for⁃
ward primer（GJB2-F）: TGCTTACCCAGACTCGAGAA
and reverse primer（GJB2-R）: CGACTGAGCCTTGA⁃
CAGCTGA, were designed for the coding region of
GJB2, and the PCR product was an 864bp fragment. In
order to amplify the exon, touch-down PCR with the an⁃
nealing temperatures of T1 = 68℃（10 cycles）and T2 =
63℃（25 cycles）was carried out in an ABI 9700 ther⁃
mal cycler.
SLC26A4 mutation screening The SLC26A4 gene con⁃
tains an open reading frame of 2,343 bp, and encompass⁃
es 21 exons. Mutations in exons 8, 19, 10, 17 and 15 are
often found in nonsyndromic hearing loss associated
with EVA in the Chinese［15］. Hence, the following se⁃
quential procedures were used to systematically detect
mutations in the SLC26A4 gene. PCR amplifications of
five exons（8, 19, 10, 17 and 15）were first performed. If
a mutation was not detected in these five exons, the
DNA sample was further screened for mutations in exons
3, 4, 5, 7, 11, 12 and 14, respectively. Exons 3, 5, 8 and
15 were amplified using the primer pairs described pre⁃
viously［16］, which were designed using the online Primer
3.0 software. For exons 4, 7, 10, 11, 12, 14, 17 and 19,
the primer pairs were designed based on those in Van
Laer et al［17］. All the primer pairs were synthesized by
Shanghai Sangon Biological Engineering Technology
and Services Co. Ltd（Shanghai, China）. Touch-down
PCR with conditions as described by Guo Y-F et al［１６］
was conducted for amplifying exons 3, 5, 8 and 15 in an
ABI 9700 thermal cycler. The other exons were ampli⁃
fied according to the reaction conditions described by
Van Laer et al［17］.
Mitochondrial DNA A1555G mutation screening With
the use of the primer pair synthesized by Shanghai San⁃
gon Biological Engineering Technology and Services Co.
Ltd-forward primer（M-F）: TCAACCTCACCACCTCTT
and reverse primer（M-R）: TTTGTCGCCTCTACCTAT,
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Table 1 List of genetic resources collected
Classification
Pedigrees, dominance
Pedigrees, recessive
Pedigrees, GJB2
Pedigrees, EVA
Pedigrees, A1555G
Pedigrees, X-linked
Pedigrees, Y-linked
Pedigrees, total
Cases, AN
Cases, SHL
Cases, total
Newborns screened
N
28
607
147
230
100
7
1
1,120
169
1,283
1,452
5,914
a 767 bp mtDNA fragment（nt1229~nt1995）was ampli⁃
fied using the annealing temperature of T=62℃ for 30
cycles. Alw26I digestion analysis was also used for de⁃
tecting mtDNA A1555G. A volume of 6.0 μl of the PCR
product was mixed with 2.0 μl of buffer and 0.2 μl of
Alw26I restriction enzyme（Tango, Shanghai, China）.
ddH2O was added to the mixture till the volume reached
25.0 μl. The reaction mixture was incubated at 37℃ for
150 minutes. The electrophoresis on the 2% agarose gel
was run to examine the digested product. If the digested
product showed the specific band for mtDNA A1555G,
the PCR product was verified by direct sequencing.
3. Data analysis
Linkage analysis First, simple familial aggregation
and transmission analysis was performed to identify the
most likely inheritance models for the investigated fami⁃
lies, after non-genetic environmental causes were ex⁃
cluded. Then, a genome-wide model-based linkage
analysis was performed, and two point or multi-point
logarithm of odds（LOD）scores between the disease lo⁃
cus and markers were calculated by LINKAGE software
［18］ or GENEHUNTER software［19］. For X-linked fami⁃
lies, linkage analysis in X chromosome was implement⁃
ed with X-linked microsatellite markers and linkage evi⁃
dence was determined per chromosomewide signifi⁃
cance. Following linkage analysis, candidate genes with⁃
in the 95% confidence intervals of the mapped loci were
investigated and genetic variants were screened by se⁃
quencing or other means.
Candidate gene approach Genetic epidemiological
studies of several common hearing loss genes in the Chi⁃
nese population were conducted using candidate gene
approach to establish their influence on the Chinese at
large. To obtain the population genetic parameters such
as mutation rates and genotypic relative risks, an exten⁃
sive screening of mutations in the candidate genes was
conducted for different geographic regions or nationali⁃
ties in this largest eastern country. In our studies, three
common genes （mtDNA 12S rRNA, GJB2 and
SLC26A4）were focused on. For sporadic patients or au⁃
tosomal recessive pedigrees with profound or fluctuating
hearing loss, or patients with a history of exposure to oto⁃
toxic medications, we used the candidate approach to
characterize the genetic epidemiological profiles in Chi⁃
nese deaf patients. Also, the three genes were used as
the targets in our newborns screening.
Results
1. The national network of China for collecting the
genetic resources related to hearing loss
The national network was constructed in 2000 and
maintained since then by Institute of Otolaryngology,
Chinese PLA General Hospital. The China Disabled Per⁃
sons' Federation and numerous local societies（in provin⁃
cial, municipal and county jurisdictions）have provided
consistent help in the largest campaign for collecting ge⁃
netic resources（pedigrees and sporadic cases）related to
hearing loss. Currently, this network covers more than
20 provincially administrated regions including. The
largest database has documented a total of 1,120 sim⁃
plex or multiplex pedigrees of different inheritances, and
1,452 sporadic cases（Table 1）. In addition, this data⁃
base restores the detailed clinical data and genetic test⁃
ing for three common hearing loss genes（mtDNA 12S
rRNA, GJB2 and SLC26A4）for 5,914 newborns coming
from eight provincial jurisdictions（Table 1）. These re⁃
sources provide us rich materials for developing rigorous
projects in both clinical and basic scientific research in
the domain of hearing science, and consequently for de⁃
fining better intervention measures delivered to hearing
impaired patients in China.
2. Large-scale genetic studies for identifying the
unique mutation spectrum and high-risk loci in
Chinese population
There is a worldwide interest in studying the pathogen⁃
··101
Journal of Otology 2009 Vol. 4 No. 2
ic variants, especially in the three common hearing loss
genes（mtDNA 12S rRNA, GJB2 and SLC26A4）that con⁃
fer high cross-race risks to multiple ethnic backgrounds
and populations. Nevertheless, increasing evidence from
previous studies indicates that not only the mutation
rates are distinct, but also the genetic loci/variants can
be quite different among different races. In several stud⁃
ies, we performed large-scale genetic studies of the
three genes in order to develop reliable genetic testing
for the Chinese population. In total, we have screened 2,
567（either familial or sporadic）patients for 12S rRNA
1555G and GJB2 or SLC26A4 mutations. These
large-scale efforts identified Chinese specific mutation
hotspots and defined the unique spectrum［15］. In the
study of 801 patients collected in the northwest re⁃
gions（mainly Gansu province）［16］, 26.2% were found
to result from mutations in the three genes and the muta⁃
tion rate was 8.4% for mtDNA A1555G, 9.0% for GJB2
and 8.8% for SLC26A4, respectively. About 12% of the
patients were GJB2 or SLC26A4 mutation-wild heterozy⁃
gotes. As a result, the cumulative 38% of the patients
were associated with genetic variations in the three com⁃
mon genes. This genetic epidemiological study also dem⁃
onstrated that 26.2% of the prelingual deafness in north⁃
ern China could be detected at young ages by genetic
testing of the three common hearing loss genes, allowing
early intervention to help them in language acquisition.
Among the 1,120 pedigrees collected, 147 were found
to have hearing loss resulting from GJB2 homozygotes or
compound heterozygotes. Hearing loss in the 230
EVA pedigrees was due to SLC26A4 homozygotes or
compound heterozygotes. And in 100 families, hearing
loss was caused by 12SrRNA A1555G mutation. Hearing
loss was from 12SrRNA C1494T in 3 pedigrees. All the
pedigrees had two or more affected members and 42.8%
of the pedigrees were associated with mutations in the
three genes, while the cause of deafness was unknown in
the remaining 57.2% families .
In the study［15］, 107 patients with EVA recruited from
May 2003 to Dec. 2005 received comprehensive audio⁃
metric evaluation, imaging scanning of their ears and
SLC26A4 mutation screening. The audiometric tests in⁃
cluded play audiometry or pure tone audiometry, tympa⁃
nometry, middle ear muscle reflex thresholds and stape⁃
dius muscle reflex（acoustic and nonacoustic）, otoacous⁃
tic emissions（OAEs）, and auditory brain stem respons⁃
es （ABRs）. High-resolution computed tomography
（CT）scan of the temporal bone and magnetic resonance
imaging（MRI）were used to examine structures of the
cochlea and endolymphatic sac. All 21 exons of the
SLC26A4 gene were sequenced. Of the EVA patients,
70% were found having a significant A-B gap at low fre⁃
quencies（500 and 250 Hz）, covering a span of 15-95
dB HL. In 75% of the patients, the short latency nega⁃
tive response（ASNR）was evoked during the routine
ABR testing. The latency of ASNRs was 3.26 ± 0.57
ms. In this study, SLC26A4 gene mutations were detect⁃
ed in 97.9% of the EVA patients. Based on these find⁃
ings, we developed a systematic diagnosis procedure in⁃
tegrating audiometric tests, CT and MRI scans, and
SLC26A4 gene test［20, 21］.
3. Positional cloning based on Chinese pedigrees
and searching for novel loci candidate gene muta⁃
tions
As shown in Table 2, the novel loci identified in our
lab were nominated as DFNC1, DFNA55 and DFNA56
in the autosomal dominant inheritance pedigrees. Of the
eight large pedigrees, the Z002 pedigree was mapped on⁃
to the DFNA4 locus at 19q13.2-13.4, and the F013 ped⁃
igree onto 9q31.3-34.3（nominated as DFNA56）. The
novel locus DFNC1 at 12p11.23-13 for autosomal domi⁃
nant conductive hearing loss with congenital ptosis was
identified using a four-generation pedigree with nine pa⁃
tients affected by this disorder. The Z029 pedigree was
mapped onto 11q13.4-22.1, the 686 pedigree onto
9p13.2-13.3（nominated as DFNA55）, and the
727 pedigree onto 1p31-35, a region partially overlap⁃
ping with DFNA47. The linkage for the remaining two
pedigrees（1301 and 1318）was yet to be characterized.
Besides the autosomal dominant gene mappings, two
novel mutations in POU3F4 causing congenital pro⁃
found sensorineural hearing loss were found in two Chi⁃
nese X-linked pedigrees［22-24］. The first pedigree repre⁃
sented an exceptional case of more than eight males af⁃
fected in one family with the phenotype of profound hear⁃
ing loss leading to deaf-mutism caused by a POU3F4 de
novo mutation that had not been reported before. Muta⁃
tion screening of POU3F4 revealed a de novo missense
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Pedigrees
Z002
F013 (DFNA56)
DFNC1
Z029
686 (DFNA55)
727
1301
1318
Geographic origin
Jianxi
Shandong
Liaoning
Hebei
Henan
Liaoning
Shandong
Henan
No subjects
85（6 generations）
40（4 generations）
44（4 generations）
84（6 generations）
63（5 generations）
44（4 generations）
61（6 generations）
102（5 generations）
DNA samples
37
31
19
49
30
16
29
39
No of patients
14
11
9
19
11
8
17
15
Age of onset (yrs)
20-35
8-30
congenital
13-40
21-55
8-20
12-42
4-18
Location
19q13.2-13.4
9q1.3-34.3
12p12.3-13.2
11q13.4-22.1
9p13.2-13.3
1p31-1p35
working on
working on
Table 2 Linkage results for eight Chinese pedigrees following inheritance of autosomal dominance
substitution（925T > C） in the well-known deaf gene.
Very recently, another novel mutation in this gene was
identified in another independent Chinese pedigree with
CPSHI collected by our lab（unpublished data）.
In the positional cloning study, we mapped the first
X-linked locus for auditory neuropathy, AUNX1, in a
Chinese family［25, 26］. We also mapped a Y-linked hear⁃
ing impairment family on Y chromosome, nominated as
DFNY1 locus. Recent studies showed that a novel mech⁃
anism was responsible for the deafness phenotype［5, 27-29］.
Discussion and perspective
In the last decade, genetic studies of hearing loss in⁃
cluding positional cloning of the underlying genes, func⁃
tional characterization of the identified candidate genes
and large-scale population-based epidemiological in⁃
vestigation of mutations in common hearing loss genes
in various races have provided us insights onto the mo⁃
lecular basis for the human auditory system, and thus
new conceptions of diagnosis, prevention and ultimate
cure for the most common communication disorder
worldwide［30］. Further advances in the field to establish
the molecular pathways or correlates to the observed
clinical phenotypes would allow researchers and otology
clinicians to view and interpret development of this dis⁃
ease from new standpoints. Since the first gene for nonsy⁃
dromic hearing loss was identified in 1995, up to 146 ge⁃
netic loci have been mapped and 46 disease genes have
been cloned in 30% of the loci identified（http://web⁃
host.ua.ac.be/hhh/）. Some scientists reckon that the
number of genes related to human auditory system takes
up 1%（250-300）of the total number of human genes
（25, 000-30, 000）［31］. However, we have to recognize
that follow-up positional cloning effort takes much lon⁃
ger than identification of the susceptibility loci for hear⁃
ing loss. The only exceptions are 1998 and 2001 when
seven hearing loss genes were cloned in the respective
year, giving an overoptimistic impression that the genet⁃
ic basis for human auditory system could be fully decod⁃
ed in the near future. However, with discoveries of a
large number of new genetic loci for varied clinic audio⁃
logical phenotypes, high heterogneities presented in sev⁃
eral well-studied genes, multiple causal genes at a sin⁃
gle Mendelian inheritance locus and modifier genes as
well as evolutionary divergence of founder’s mutation, it
is agreed by more people that fully deciphering the mo⁃
lecular pathways of human hearing functionalities is still
a very challenging task［6, 31］.
In our otology clinic, when children with congenital
profound hearing loss come, clinicians can reasonably
believe that their symptoms may result from a GJB2 mu⁃
tation at DFNB1 locus. This likelihood is 20%-50% .
Likewise, when a patient is found sensitive to aminogly⁃
coside ototoxicity and also has 12S rRNA 1555G, our cli⁃
nicians will suggest averting the use of this type of
drugs. When a patient is found having a POU3F4 muta⁃
tion, the clinician will alert that the patient may be at
risk of stapes gushers when an inner ear surgery is per⁃
formed. Finally, early interventions may be given to an
EVA patient with SLC26A4 mutation to prevent his pro⁃
gressive hearing loss. In short, the recent advance in ge⁃
netic studies of hearing loss is becoming an integrative
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component in designing most effective diagnosis for
hearing loss and in delivering solid and convincing ad⁃
vices to patients in otology clinic.
Nevertheless, before the genetic architecture underly⁃
ing hereditary hearing phenotypes is fully understood,
we have to face challenges in improving current clinic
practice and research for hearing loss because of the par⁃
tial or fragmented genetic knowledge accumulated so
far. Large amount of work is to be completed, including
deciphering the mutation-induced molecular mecha⁃
nisms, biochemical or pathogenic pathways leading to
varied phenotypes of hearing loss and phenotypic hetero⁃
geneities. For examples, among the GJB2-induced pro⁃
found hearing loss, the patients have different forms of
mutations at the same（mutant homozygote）or different
loci（compound heterozygotes）. In some cases, both the
patient and his parent(s) have one mutant, but the parent
’s hearing is normal. Among SLC26A4-induced EVA
patients, more than 164 mutation types have been identi⁃
fied［15］, but the resulted clinical phenotypes are largely
indistinguishable from each other. For late onset hearing
loss of dominant inheritance, it is unclear why patients
with in-born pathogenic mutation demonstrate progres⁃
sive hearing loss in their first or second decade. It re⁃
mains a myth how environmental factors, post-transcrip⁃
tion DNA methylation and various modifiers interplay
with the underlying genetic network in the human audito⁃
ry system. Some scientists estimate that 250-300 genes
are related to the system, but only slight more than 70
genes are cloned. Pathogenic genetic factors for varieties
of hearing loss phenotypes, such as noise-induced,
age-related, idiopathic and neuropathy-associated hear⁃
ing loss, are yet to be identified. To further understand
the underlying functional mechanisms, mouse models
may prove promising. However, translation of findings in
these models to humans remains a challenging and is a
largely unresolved issue. Although we are now in the
stage of developing a matured molecular diagnosis for
various types of hearing loss, congenital profound senso⁃
rineural hearing loss in particular, the studies for
post-diagnosis intervention are largely in infancy.
Among others, regeneration of hair cells, gene therapy
and development of personalized medication are likely
future targets in the domain of otology clinic and science.
In otology clinics, early diagnosis and subsequently
timely intervention are becoming the most effective strat⁃
egy for improving hearing care in the largest population
in the world. There are 800,000 deaf children under sev⁃
en years of age in China. If we are able to fully imple⁃
ment a national newborn genetic screening program,
based on the knowledge that approximately 30% of deaf
children are a result of gene mutations, 240,000 chil⁃
dren are expected to receive timely intervention to avoid
complete loss of their communication ability. In the
meantime, 72 billions yuan of medical cost can be
saved. In China, a yearly increment is the births of ap⁃
proximately 30,000 deaf children. Based on these num⁃
bers, genetic testing can help one third of these children
and save 3,000 millions yuan for China. Therefore, we
advocate an integration of genetic testing into the exist⁃
ing newborn screening program. This conception will
lead to identification of deaf mutation carriers in 3% of
the populations. With planned birth in Chinese families,
a substantial reduction in the genetic load and therefore
the incidence rate of hearing suffers in the next genera⁃
tion of this population is possible.
Ａcknowlegment
This work was supported by grants from the National
High Tech Development Project(No. 2006AA028 Z181), the
National Natural Science Foundation of China，Key Project
(No. 30830104), the National Natural Science Foundation of
China(No. 30771857, 30672310 & 30771203), the Foundation
of National Excellent Doctoral Thesis (No. 200463), Beijing
Nature Science Technology Major Project(No. D0906005
040291 & 7070002), the National 973 Project(No. 2007CB
507400) as well as the National Eleventh Scientific Pro⁃
gram(No. 2006BAI02B06& 2007BAI18B12) and the Sun
Yat-Sen University Start-up Fund (Grant No. 3171310).
References
1 Morton NE. Genetic epidemiology of hearing impairment. Ann
N Y Acad Sci. 1991, 630: 16-31.
2 Lalwani AK, Castelein CM. Cracking the auditory genetic
code: nonsyndromic hereditary hearing impairment. Am J Otol.
1999，20: 115-132.
3 Morton CC. Genetics, genomics and gene discovery in the audi⁃
tory system. Hum Mol Genet, 2002，11: 1229-1240.
4 Morton CC, Nance WE. Newborn hearing screening-a silent
revolution. N Engl J Med, 2006, 354: 2151-2164.
··104
Journal of Otology 2009 Vol. 4 No. 2
5 Wang QJ, Lu CY, Li N, et al. Y-linked inheritance of
non-syndromic hearing impairment in a large Chinese family. J
Med Genet, 2004, 41: e80.
6 Schrijver I, Gardner P. Hereditary sensorineural hearing loss:
advances in molecular genetics and mutation analysis. Expert Rev
Mol Diagn. 2006, 6: 375-386.
7 Gurtler N, Lalwani AK. Etiology of syndromic and nonsyn⁃
dromic sensorineural hearing loss. Otolaryngol Clin North Am.
2002，35: 891-908.
8 Kudo T, Ikeda K, Kure S, et al. Novel mutations in the connex⁃
in 26 gene（GJB2）responsible for childhood deafness in the Japa⁃
nese population. Am J Med Genet. 2000, 90: 141-145.
9 Zelante L, Gasparini P, Estivill X, et al. Connexin26 muta⁃
tions associated with the most common form of non-syndromic
neurosensory autosomal recessive deafness（DFNB1）in Mediterra⁃
neans. Hum Mol Genet. 1997, 6: 1605-1609.
10 Abe S, Usami S, Hoover DM, et al. Fluctuating sensorineural
hearing loss associated with enlarged vestibular aqueduct maps to
7q31, the region containing the Pendred gene. Am J Med Genet.
1999, 82: 322-328.
11 Usami S, Abe S, Weston MD, et al. Non-syndromic hearing
loss associated with enlarged vestibular aqueduct is caused by
PDS mutations. Hum Genet. 1999, 104: 188-192.
12 Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ri⁃
bosomal RNA mutation associated with both antibiotic-induced
and non-syndromic deafness. Nat Genet. 1993, 4:289-294.
13 Li R, Xing G, Yan M, et al. Cosegregation of C-insertion at
position 961 with the A1555G mutation of the mitochondrial 12S
rRNA gene in a large Chinese family with maternally inherited
hearing loss. Am J Med Genet A, 2004, 124: 113-117.
14 Stephens D. Definitions, protocols & guidelines in genetic
hearing impairment. In: Martini A, Mazzoli M, Stephens D, Read
A, eds. Audiological terms. Letchworth, UK: Whurr Publishers,
2001.
15 Wang QJ, Zhao YL, Rao SQ, et al. A distinct spectrum of
SLC26A4 mutations in patients with enlarged vestibular aqueduct
in China. Clin Genet. 2007, 72: 245-254.
16 Guo Y-F, Liu X-W, Guan J, et al. GJB2, SLC26A4 and mito⁃
chondrial DNA A1555G mutations in prelingual deafness in North⁃
ern Chinese. Acta Oto-Laryngologica 2008: in press.
17 Van Laer L, Coucke P, Mueller RF, et al. A common founder
for the 35delG GJB2 gene mutation in connexin 26 hearing impair⁃
ment. J Med Genet. 2001, 38: 515-518.
18 Li L, Wang QK, Rao S. LINKAGE programs: linkage analysis
for monogenic cardiovascular diseases. Methods Mol Med, 2006,
128: 41-60.
19 Kruglyak L, Daly MJ, Reeve-Daly MP, et al. Parametric and
nonparametric linkage analysis: a unified multipoint approach.
Am J Hum Genet. 1996, 58: 1347-1363.
20 Lan L, Li-Ming Y, Zhi-Hui C, et al. Significance of ASNR in
the diagnosis of enlarged vestibular aqueduct. Journal of Audiolo⁃
gy and Speech Patholog. 2006, 14: 241-244.
21 Wang Q-J, Han D-Y, Lan L, et al. A strategy study for diag⁃
nosis and tr eatment of large vestibular aqueduct syndrome. Chi⁃
nese Journal of Otology. 2006, 4: 315-321.
22 Bitner-Glindzicz M, Turnpenny P, Hoglund P, et al. Further
mutations in Brain 4（POU3F4） clarify the phenotype in the
X-linked deafness, DFN3. Hum Mol Genet. 1995, 4: 1467-1469.
23 Vore AP, Chang EH, Hoppe JE, et al. Deletion of and novel
missense mutation in POU3F4 in 2 families segregating X-linked
nonsyndromic deafness. Arch Otolaryngol Head Neck Surg. 2005,
131: 1057-1063.
24 de Kok YJ, van der Maarel SM, Bitner-Glindzicz M, et al. As⁃
sociation between X-linked mixed deafness and mutations in the
POU domain gene POU3F4. Science. 1995, 267: 685-688.
25 Wang Q, Gu R, Han D, et al. Familial auditory neuropathy.
Laryngoscope. 2003, 113: 1623-1629.
26 Wang QJ, Li QZ, Rao SQ, et al. AUNX1, a novel locus respon⁃
sible for X linked recessive auditory and peripheral neuropathy,
maps to Xq23-27.3. J Med Genet, 2006，43:e33.
27 Petersen MB, Wang Q, Willems PJ. Sex-linked deafness.
Clin Genet. 2008, 73: 14-23.
28 Wang QJ, Han DY, Yang WY. Detection of POU3F4 gene
mutations in the Chinese pedigree with Y-linked hereditary hear⁃
ing impairment. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za
Zhi. 2005, 40: 323-326.
29 Wang QJ, Rao SQ, Zhao YL, et al. The large Chinese family
with Y-linked hearing loss revisited: clinical investigation. Acta
Otolaryngol. 2009, 129: 638-643.
30 Hilgert N, Smith RJ, Van Camp G. Forty-six genes causing
nonsyndromic hearing impairment: which ones should be analyzed
in DNA diagnostics? Mutat Res. 2009，681: 189-196.
31 Friedman TB, Griffith AJ. Human nonsyndromic sensorineu⁃
ral deafness. Annu Rev Genomics Hum Genet. 2003, 4:
341-402.
（ＲeceivedＭay 4,２００９）
··105
